Real-time enrollment status for this acute coronary syndromes (acs) clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:36 AM UTC
| NCT Number | NCT07619885 |
| Recruiting Status | Recruiting |
| Condition | Acute Coronary Syndromes (ACS) |
| Phase | PHASE1 |
| Target Enrollment | 136 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Shanghai CureGene Pharmaceutical Co., Ltd. |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of August 31, 2026: Clinical trial NCT07619885 is currently recruiting participants. This phase1 study for acute coronary syndromes (acs) is actively seeking new participants at 1 location across the United States. The study is sponsored by Shanghai CureGene Pharmaceutical Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07619885 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07619885 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.